Recent insider actions at ACM Research Inc (ACMR) are drawing investor attention. On November 13, 2025, Feng Lisa sold $506,550 worth of shares, offloading 15,000 shares at $33.77 each. Following this transaction, their holdings fell to 50,001 shares valued at about $1.64 million.
In another sale, Feng Lisa disposed of an additional 15,000 shares at $32.76 apiece, generating proceeds of over $491,400. After these transactions, the insider’s remaining holdings stayed at 50,001 shares.
Earlier, LISA YI LU FENG had purchased 15,000 shares at $33.79 each, totaling $506,796. These alternating buy and sell moves have stirred speculation about insider sentiment.
Analyst Ratings
Wall Street analysts are mixed but leaning positive. JP Morgan initiated coverage on February 28, 2025, with an Overweight rating and a revised price target of $36. Later in February, Craig Hallum upgraded ACMR from Hold to Buy. However, earlier in December 2024, Craig Hallum downgraded the stock from Buy to Hold, and Needham also shifted its rating to Hold. Despite shifting stances, the current environment shows growing optimism.
Stock Performance
In the latest trading session, ACMR dipped 0.69% to close at $32.87. The stock fluctuated between a low of $32.50 and a high of $33.62. Despite the dip, ACMR has climbed 4.35% over the past five days and surged 74.93% year-to-date. The stock has ranged from a 52-week low of $14.97 on January 13, 2025, to a high of $45.12 on October 2, 2025.
Support and Resistance
Charts indicate a support level at 32.37, with potential decline to 31.88 if broken. Resistance lies at 33.49, followed by 34.12. The 14-day RSI is 46.12, signaling neutral technical momentum.
Short Interest
Short interest saw a significant jump on November 14, 2025, rising by 0.1 million shares to 4.52 million. Compared with 4.41 million on October 15, this marks a 2.22% increase, suggesting growing bearish sentiment. Short positions account for 3.31% of the float, and the days-to-cover ratio now stands at 3.31.
Major Shareholders and Price Targets
Analysts surveyed by FactSet set an average 12-month price target of 40, offering about 20.85% upside from the previous close of $33.10. Projections place the stock near 40 by 2025, with 19 analysts rating ACMR as a Buy by year-end. On February 29, 2024, Goldman upgraded the stock to Buy with a $39 target.
